DiaspoCare

DiaspoCare provides a technology platform for financial transactions that allows members of the African Diaspora to manage the health and well being of their loved ones back home, with quality, transparency and affordability. The platform drives a double-sided network effect by bringing service providers and consumers into a cost-efficient marketplace, tailor made for the complexities of healthcare, international exchange and mobile money.

Bookmarks

Raised 100 % of minimum

Funding Raised

$187,500

Funding Goal

$10,000-$1,234,000

Days Left to Invest

3 Days

Invest Now

DiaspoCare

DiaspoCare provides a technology platform for financial transactions that allows members of the African Diaspora to manage the health and well being of their loved ones back home, with quality, transparency and affordability. The platform drives a double-sided network effect by bringing service providers and consumers into a cost-efficient marketplace, tailor made for the complexities of healthcare, international exchange and mobile money.

Raised 100 % of minimum

Funding Raised

$187,500

Funding Goal

$10,000-$1,234,000

Days Remaining

3 Days

Invest Now

Business Description

Starting with pharmacies, the DiaspoCare fintech platform now services a broad range of both healthcare and other services, such as life insurance. Onboarding of new service providers and new service offerings has accelerated in 2022, showing the extensibility and flexibility of the platform. As of May 2022, DiaspoCare now connects the Diaspora with pharmacies, clinics, hospitals, medical specialists, telemedicine, second opinion, health insurance, life insurance, and funeral insurance. The business model is two-sided, with commissions and fees being collected on either the service provider side or the consumer side. Furthermore, because of the international currency exchange nature of their financial products, there is additional revenue generated for DiaspoCare as a result of the exchange. Wrapping together their entire portfolio is their Care Management and Concierge services, an additional revenue source, with provides further peace of mind through “high touch” coordination of services for the loved ones that the Diaspora are caring for back home. The short term business plan of DiaspoCare is to continue to accelerate the growth of their user base, both on the service provider side and the consumer side through expansion of their marketing efforts and direct outreach. This business plan expands over time to include more countries in Africa, Asia and Latin America, and more products and services for any of the needs of the world’s diaspora and migrant communities.

Problem

The founders of DiaspoCare created their platform in 2018 to solve the problems they faced taking care of their loved ones back home. All too often, funds sent to family members to pay for their medical expenses were not used for their intended purpose. Funds might be diverted to other pressing obligations, or spent on sub-standard care, and their health suffers as a result. Transfer fees eat up a large portion of the remittance and the complexities of sending money encourages sending large sums, hoping that the money would go a long way. But this only further intensifies the problem of diverted funds.

Solution

The DiaspoCare founders created a fintech platform where they could provide micropayments directly from the Diaspora to the healthcare service providers, insuring that remitted funds were spent as intended. This gives complete transparency and control, while saving considerably on fees and time delays. The DiaspoCre fintech platform is fully integrated with the latest mobile money systems very common in Africa, meaning that from the smallest to the largest, healthcare service providers can use the financial tools they are comfortable with. As a solution created by the African Diaspora, for the African Diaspora, it also provides “shared funding” wallets that emulate how large family groups have traditionally pooled their funds for shared benefit. Originally built for pharmacies and clinics, the DiaspoCare fintech platform has proven its flexibility by quickly expanding into many aspects of caring for family members remotely. It now provides a marketplace where the Diaspora can get telemedicine, expert second healthcare opinion, purchase life insurance and other forms of insurance.

Business Model

The business model is two-sided, with commissions and fees being collected on either the service provider side or the consumer side. This is similar to other “Fintech” platforms (like Uber or VRBO) where buyers can advertise their services and sellers can purchase those services directly. Furthermore, because of the international currency exchange nature of their financial products, there is additional revenue generated for DiaspoCare as a result of the exchange. Wrapping together their entire portfolio is their Care Coordination and Concierge services, an additional revenue source, with provides further peace of mind through “high touch” coordination of services for the loved ones that the Diaspora are caring for back home. The short term business plan of DiaspoCare is to continue to accelerate the growth of their user base, both on the service provider side and the consumer side through expansion of their marketing efforts and direct outreach. The DiaspoCare business is focused on an underserved and untapped market in the African Diaspora living abroad, but is also in high demand in-country and in-region, wherever workers migrate away from their families. This business plan expands over time to include more countries in Africa, Asia and Latin America, and more products and services for any of the needs of the world’s diaspora and migrant communities.

Market Projection

The target market for the initial launch of DiaspoCare focuses on healthcare remittances in Kenya, Nigeria and Ghana. In these three countries alone, 20 million African migrants send $7.2b in healthcare remittances. DiaspoCare’s initial focus is on the management of chronic disease. With the average spend of $50 per transaction, our target net revenue for chronic disease maintenance is $75m.

Competition

DiaspoCare provides services in an ecosystem with well established, niche players that provide aspects of the DiaspoCare solution. For example, Moneygram and Western Union are remittance companies, Fleri and My Dawa are healthcare coordination companies, Miesha Meds provides pharmacy services and Jubilee offers insurance. But no company exists that offers an extensible, flexible fintech platform for any accredited healthcare service providers to sell their services directly to the Diaspora. Our two-sided business model is also unique, which allows us to spread our costs and capture revenue from both service providers and consumers. Rather than compete on point solutions, the DiaspoCare platform approach turns competitors into business partners, driving down costs across the ecosystem and connecting previously disconnected consumers with service providers.

Traction & Customers

The DiaspoCare fintech platform has been in full public operation since May, 2021. After incorporating in May 2018, DiaspoCare began development of our technology platform, which went into limited pilot operations the following year as we continued to test, refine and enhance our offering. For the following two years, DiaspoCare expanded into three countries: Kenya, Ghana and Nigeria. Our service provider network has expanded to over 600 pharmacies and 230 clinics and hospital systems. Because our technology platform allows for quick onboarding of new service offerings, we now offer access to telemedicine, second medical opinion, health insurance and life insurance, in addition to our initial capabilities for pharmacy and clinic services. In the first four months of 2022, DiaspoCare’s operations have accelerated significantly. Transaction counts increased 60%, user accounts grew 50%, beneficiaries on the platform increased 70%, pharmacies increased 20% and clinics have over tripled in number. This rapid acceleration in traction demonstrates the maturity of the DiaspoCare technology platform. New service providers are quickly added to the platform with minimal overhead. As a leading indicator of the excitement of our service delivery partners, DiaspoCare now has seven co-branding / co-marketing MOUs (Memo of Understanding) signed across the healthcare delivery ecosystem. These partnerships are exceptionally valuable, as they bring outside funding for DiaspoCare marketing.

Investors

The DiaspoCare founders have directly funded the development of the fintech platform and the creation of local operations teams in Kenya, Ghana and Nigeria. Building the platform has required many iterations, as the team tested their product in the real world, adjusted and adapted to fit a challenging market. This has required significant investment over the last four years, including technology and business development as well as operations expenses during that period. These investments have allowed DiaspoCare to integrate with major banking and mobile payment companies in Kenya, Nigeria and Ghana. This has required significant technology development investment for both the DiaspoCare operations platform and mobile apps.

Terms

This is an offering of a SAFE, under registration exemption 4(a)(6), in DCare Inc. with a discount rate of 80%. This offering must raise at least $10,000 by April 1st, 2024 at 11:59 pm ET. If this offering doesn’t reach its target, then your money will be refunded. DCare Inc. may raise up to $1,234,000, the offering’s maximum.

Risks

See Offering Statement; A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment.
In making an investment decision, investors must rely on their examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature.
These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.

Neither PicMii Crowdfunding nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.

The information contained herein includes forward-looking statements. These statements relate to future events or future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Security Type:

SAFE

Discount Rate

80%

Post Money Valuation:

N/A – SAFE

Investment Bonuses!

None

Regulatory Exemption:

Regulation Crowdfunding – Section 4(a)(6)

Deadline:

April 1, 2024

Minimum Investment Amount:

$1000

Target Offering Range:

$10,000-$1,234,000

*If the sum of the investment commitments does not equal or exceed the minimum offering amount at the offering deadline, no securities will be sold and investment commitments will be cancelled returned to investors.


Serge Alain Wandji
Chief Executive Officer – Cofounder
BackgroundSerge is a co-founder, President and CEO of DiaspoCare, LLC, a startup in healthcare delivery and digital payments. Serge was recently vice president of strategy, business development and innovation at Children’s Hospitals and Clinics of Minnesota. Prior to that, Serge was senior intellectual asset manager at Cargill, senior intellectual property associate for Colgate Palmolive Company, assistant director of technology development and assistant professor in the department of pharmacology at Penn State College of Medicine, where he co-founded Verefi Technology, a startup that developed surgical simulators. Serge-Alain was a co-founder and COO of NextPakk, a last-mile package delivery service secured with blockchain technology and is currently Chair of the board of Agricycle Global and a member of the steering committee of ScaleHealth. Bachelor’s degree in animal science, Master’s degree in neurophysiology and PhD in physiology from Laval University, Quebec. Post-doctoral fellow in bio-medical sciences at Cornell University and Master’s degree in technology management from the University of Pennsylvania Wharton School of Business and School of Engineering.

Jote Taddese
Chief Operations Officer, Chief Information Officer
BackgroundJote brings over 20-Years of experience as a customer-centric IT executive with proven outcomes of influencing, shaping and executing enterprise strategies that take data and translate into meaningful digital transformations which enable C-Suite business executives to incorporate new insights into their decision-making processes. He is a proven industry thought leader with many years in senior leadership roles with strategic accountabilities in the areas of Data Monetization, Enterprise Data Architecture and Digital Transformation capabilities. In addition to being a C-Suite strategic advisor, a board executive and a social entrepreneur, Jote is also a connector of individual strengths to make dreams come true by approaching every interaction as an opportunity to inspire others and look for what is possible versus focusing on the problem. He is a Lifetime-Learner, a Coach and a Mentor focused on fostering a culture of curiosity to inspire entrepreneurial spirit, innovation and co-creation in order to deliver meaningful business value in global and matrixed organizations.

Dr. Edwin Bokongo
Chief Medical Officer
BackgroundDr. Bokongo the the Medical Director and Lead Hospitalist at St. Francis Regional Medical Center in Shakopee, Minnesota, where he has practiced since 2007. Dr. Bokongo’s compassionate and innovative approach to healthcare has been recognized by his patients, fellow clinicians and his peers. He was elected president of the Twin Cities Medical Society in 2013. He was further recognized by the Minnesota Medical Association, where he has served on the Board of Directors, as Secretary and Treasurer, and currently as Chairman of the Board. Dr. Bokongo’s has been serving the healthcare needs of his community since he first began his career at the University of Nairobi, Kenya. As an innovative entrepreneur, he combines his day-to-day experience helping patients with his business insights derived from his industry leadership positions to provide unique insight to the healthcare startup community.

Sean O’Neil
Chief Technical Officer
Background25 years experience in healthcare technology, having designed, built and implemented some of the largest and most complex healthcare systems in the world. Sean’s deep experience in managed healthcare ranges from technology to the clinic and extends to business strategy. He currently leads the Artificial Intelligence solutions team at Optum Health. An expert in scaling systems, Sean is known for his role in rescuing the Healthcare.gov website from it’s original, troubled launch and stabilizing it to enable 20+ million Americans to gain access to health insurance. Other large systems of note include his work on the 100,000 Genome project in the UK and the design and implementation of the National Genomics Information System for NHS England – the world’s first end-to-end genomic test ordering service implemented at the point of care for an entire country. Sean’s experience with healthcare in Africa dates back to 2012, where he opened his first pharmacies in Ivory Coast. Utilizing extremely cheap Raspberry Pi mini-computers (less than $100 USD), Sean was able to bring digital healthcare management to remote areas of Africa.

Mike Essien
Chief Legal Counsel
BackgroundMike Essien is an intellectual property and business attorney and a Principal at Essien Law Office PLLC. Prior to becoming a lawyer, he worked as a product development engineer at 3M, and is named inventor on two U.S. patents. His bachelor’s in chemical engineering is form University of Oklahoma in Norman, Oklahoma and his Juris Doctorate is from Mitchell Hamline College of Law in Saint Paul, Minnesota. He is currently the Board President of Books For Africa, and also serves as board president for the Association of Nigerian Engineers in Minnesota. Mike also does consulting on research and development for several international institutes and is an Assistant Professor of Business Law at University of Wisconsin, Stout.

Mike Connly
Board of Advisors
BackgroundAfter joining UnitedHealth Group in early 2004, Mike was named Chief Information Officer of UnitedHealth Technologies (UHT). In July 2008, Mike assumed the role of Chief Technology Officer, UnitedHealth Group IT. Over several years in this role, he held responsibilities for enterprise infrastructure, enterprise architecture, software engineering methods, quality, information security, UnitedHealth Group’s India and Philippines operations, and the Innovation, Research and Development team. In late 2013, Mike joined the Optum business at UnitedHealth Group and led the Optum infrastructure team that helped stabilize the healthcare.gov website. This work continued until Mike was named CIO of Optum in 2015. He retired from UnitedHeath Group in late 2019. He joined the Board of HealthEast in 2013, was appointed chair in 2017, and led the Board through the merger with Fairview Heath Services. Mike currently serves on the Fairview Board. Previously, he was a member of the Board of Common Bond Committees, and was chair of the Minnesota High Technology Association.

Darren Klum
Board of Advisors
BackgroundDaren Klum is a high-tech executive, cyber security visionary, and hardware / software technologist. Daren is currently the CEO of Secured2 Corporation a Microsoft, Google & AWS partner that has developed the world’s first quantum-safe data security solution and a new method of data compression. Prior to Secured2 Daren founded venture-backed LiquidCool Solutions an innovator of high performance computing solutions that utilizes his patented liquid submersion cooling technology with directed flow. Daren’s corporate career spans over 20 years in various roles from product development, market development & business development for companies like Digital River, Sprint, TW Telecom and Gartner. Daren holds over 42 patents and is constantly striving to solve large market problems with his inventions. Daren is also very active in the local startup community from advising, investing and as a member of the advisory counsel for Brightstone Venture Capital.

Legal Company Name

DiaspoCare

Location

2147 University Ave West
Ste 105
St Paul, Minnesota 55114

Number of Employees

6

Incorporation Type

C-Corp

State of Incorporation

Minnesota

Date Founded

November 29, 2021

  • Last active: 2 years ago
  • 42 members
  • 0 posts
DiaspoCare
  • Group
  • Sean O'Neil
  • Starting with pharmacies, the DiaspoCare fintech platform now services a broad range of both healthcare and other services, such as life insurance. Onboarding of new service providers and new service offerings has accelerated in 2022, showing the extensibility and flexibility of the platform. As of May 2022, DiaspoCare now connects the Diaspora with pharmacies, clinics, hospitals, medical specialists, telemedicine, second opinion, health insurance, life insurance, and funeral insurance. The business model is two-sided, with commissions and fees being collected on either the service provider side or the consumer side. Furthermore, because of the international currency exchange nature of their financial products, there is additional revenue generated for DiaspoCare as a result of the exchange. Wrapping together their entire portfolio is their Care Management and Concierge services, an additional revenue source, with provides further peace of mind through "high touch" coordination of services for the loved ones that the Diaspora are caring for back home. The short term business plan of DiaspoCare is to continue to accelerate the growth of their user base, both on the service provider side and the consumer side through expansion of their marketing efforts and direct outreach. This business plan expands over time to include more countries in Africa, Asia and Latin America, and more products and services for any of the needs of the world's diaspora and migrant communities.
Hello PicMii Crowdfunding community! Please use this communication channel to ask the issuer any questions you may have regarding the offering. Happy Investing!
Please sign up or log in to comment.

Raises half the minimum amount

DiaspoCare has raised half of the target offering amount on October 27, 2023. $131,500 has been raised at this time.

Raises 100% of the minimum amount

DiaspoCare has raised the target offering amount on October 27, 2023. $131,500 has been raised at this time.Investors should be aware that the Issuer can now conduct rolling closes if they wish. If the Issuer decides to do so, you will be notified and given time to cancel your investment.
Bookmarks

Educational Material

Regulation
March 15, 2021

Make Way Venture Capitalists – SEC Updates Regulation Crowdfunding

Some Background It is no secret that venture capitalists dominate the startup space. Most startups move forward at the whim of venture capitalists just to survive. And just as you…
Regulation
February 15, 2021

The Form C

Form C - Everything You Need to Know Form C is a critical step in the crowdfunding process for all companies raising under Regulation Crowdfunding. Form C is a disclosure…
Types of SecuritiesGeneral
March 17, 2020

Types Of Securities

Types Of Securities Why do I care about the different security types available to me? Now that you are finding your inner venture capitalist, its critical that you understand what…